|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Current assets | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Advances to suppliers [Note 6] | |||||||||||||||||||
| Accounts Receivable | |||||||||||||||||||
| Inventory | |||||||||||||||||||
| Prepayments and Other Receivables [Note 6] | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Non-current assets | |||||||||||||||||||
| Equipment, net [Note 7] | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIENCY | |||||||||||||||||||
| Current liabilities | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued liabilities | |||||||||||||||||||
| Advances from a related party [Note 7] | |||||||||||||||||||
| Loan from Shareholder | |||||||||||||||||||
| Shares to be issued | |||||||||||||||||||
| Advances from a related party [Note 8] | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Stockholders’ deficiency | |||||||||||||||||||
| Preferred stock, $0.0001 par value, 5,000,000 shares authorized, Nil preferred shares outstanding at June 30 2026 (March 31, 2026: Nil), | |||||||||||||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 16,813,800 common shares outstanding as at June 30, 2026 (March 31, 2026 : 16,376,300 ) [Note 10] | |||||||||||||||||||
| Additional paid-in capital [Note 10] | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ deficiency | |||||||||||||||||||
| Total liabilities and stockholders’ deficiency | |||||||||||||||||||
Loading...
